文献速递其他结缔组织病

舍格伦与非舍格伦干燥症症状负担相似但症状相关蛋白质组学特征不同

Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature.
PubMed 文献 · RMD Open · 2022-01-01

研究比较了符合2016年ACR/EULAR标准的原发性舍格伦综合征(SjS,n=53)与非舍格伦干燥症(sicca,n=60)患者的症状与血清蛋白质组学,发现两组ESSPRI、效用值及焦虑抑郁无差异;干燥症组有20种蛋白与症状正相关而SjS组无,ADM、CD40和SPON2共同解释干燥症组51%的症状变异。

要点

  • SjS与sicca的ESSPRI、EuroQoL-5 Dimension效用值及焦虑抑郁无差异。
  • sicca组有20种蛋白与症状正相关,SjS组无蛋白与症状正相关。
  • ADM、CD40和SPON2共同解释sicca组51%的症状变异。

核心结论

  • 肥胖相关代谢因素可能调节干燥症的症状,需进一步探索SjS高症状负担的非炎症驱动因素以改善临床试验结局。

研究设计与样本

  • 采用O-link炎症与心血管II面板检测血清蛋白质组学,SjS组53例符合2016年ACR/EULAR标准,sicca组60例抗Ro阴性且表现客观或主观干燥。
  • 采用线性回归分析识别症状关键预测因子,并使用蛋白表达值完成聚类分析。

主要发现

  • ESSPRI、EuroQoL-5 Dimension效用值及焦虑抑郁在SjS与sicca之间无差异。
  • 体质指数与ESSPRI的相关性见于sicca组,在SjS组中程度较弱。
  • sicca组有20种蛋白与症状正相关,SjS组无蛋白与症状正相关。
  • 在sicca和SjS中均各识别出两个蛋白质组定义亚组,其症状负担不同;在SjS与sicca合并的层次聚类中,症状负担最高的组区分度最低。
  • ADM、CD40和SPON2共同解释sicca组51%的症状变异;ADM与ESSPRI强相关(spearman's r=0.62;p<0.0001),在校正BMI、年龄、客观干燥、抑郁和焦虑评分的多变量模型中仍相关。

关键数值与推荐

  • SjS组53例符合2016年ACR/EULAR标准;sicca组60例抗Ro阴性、表现客观或主观干燥,且唾液腺活检阴性或未行活检但认为活检不改变分类状态。
  • 干燥症组ADM、CD40和SPON2共同解释51%的症状变异。
  • ADM与ESSPRI的spearman's r=0.62,p<0.0001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需进一步探索SjS高症状负担的非炎症驱动因素以改善临床试验结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Given the similarity in symptoms between primary Sjogren's syndrome (SjS) and non-SjS sicca syndrome (sicca), we sought to characterise clinical and proteomic predictors of symptoms in both groups in order to better understand disease mechanisms and help guide development of immunomodulatory treatments. These have not, to date, unequivocally improved symptoms in SjS clinical trials. METHODS: Serum proteomics was performed using O-link inflammation and cardiovascular II panels. SjS (n=53) fulfilled 2016 ACR/European Alliance of Associations for Rheumatology (EULAR) criteria whereas sicca (n=60) were anti-Ro negative, displayed objective or subjective dryness, and either had a negative salivary gland biopsy or, in the absence of a biopsy, it was considered that a biopsy result would not change classification status. Linear regression analysis was performed to identify the key predictors of symptoms. Cluster analysis was completed using protein expression values. RESULTS: EULAR-Sjögren's-Syndrome-Patient-Reported-Index (ESSPRI), EuroQoL-5 Dimension utility values, and anxiety and depression did not differ between SjS and sicca. Correlations between body mass index (BMI) and ESSPRI were found in sicca and to a lesser extent in SjS. Twenty proteins positively associated with symptoms in sicca but none in SjS. We identified two proteomically defined subgroups in sicca and two in SjS that differed in symptom burden. Within hierarchical clustering of the SjS and sicca pool, the highest symptom burden groups were the least distinct. Levels of adrenomedullin (ADM), soluble CD40 (CD40) and spondin 2 (SPON2) together explained 51% of symptom variability in sicca. ADM was strongly correlated with ESSPRI (spearman's r=0.62; p<0.0001), even in a multivariate model corrected for BMI, age, objective dryness, depression and anxiety scores. CONCLUSIONS: Obesity-related metabolic factors may regulate symptoms in sicca. Further work should explore non-inflammatory drivers of high symptom burden in SjS to improve clinical trial outcomes.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Pucino V, Turner JD, Nayar S, et al. Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature. RMD Open. 2022. PMID: 35589331. doi:10.1136/rmdopen-2021-002119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。